+2
ClinCalc
For healthcare professionals including intensivists, pharmacists, and physicians, as well as students preparing for clinical practice or board exams.
Known for
For healthcare professionals including intensivists, pharmacists, and physicians, as well as students preparing for clinical practice or board exams.
Providing evidence-based clinical decision support and pharmacology education tools for healthcare professionals and students.
Target audience
Portfolio
Last updated
ICU Trials by ClinCalc
v2023.2
2.8y ago
Primary focus
Clinical decision support and medical education tools
Scale
indie
Target audience
Healthcare professionals including intensivists, pharmacists, and physicians, as well as students preparing for clinical practice or board exams.
Origin
ClinCalc was designed for clinicians seeking to utilize and understand the most recent evidence-based medicine to improve patient care.
The publisher maintains a legacy portfolio with one release in the last six months and 20% of the catalog currently classified as active.
5 apps analysed
Ad-free professional UX
Gamification milestones reduce churn via clear progress markers
Single-market publisher — every app ships only to United States.
Based on 4 of 5 apps with localized market data — more coverage rolling in as scans complete · last scanned .
1
Positive apps
0
Neutral / mixed
0
Negative apps
88/100
Avg sentiment score
The industry standard for clinical decision support, offering deeper, though less portable, trial summaries than ICU Trials.
Strategic outlook coming soon.
What fed this analysis
Provides a comprehensive medical knowledge base that competes for the same professional study time as RxHero.
While focused on nursing boards rather than pharmacology, it serves the same professional education market with high-frequency gamified testing.
Dominates the medication domain by focusing on patient adherence, creating a different but overlapping utility for drug knowledge.
Shows high release velocity and focuses on the professional communication layer of the medical workflow.
Aggregates new landmark trials in real-time, offering a more dynamic, feed-based approach to staying current.
